Heart Rate News and Research

RSS

Heart rate is determined by the number of heartbeats per unit of time, typically expressed as beats per minute (BPM), it can vary with as the body's need for oxygen changes, such as during exercise or sleep.

Moderate consumption of 'energy drinks' can improve people's response time

Moderate consumption of so-called energy drinks can improve people's response time on a lab test measuring behavioral control, but those benefits disappear as people drink more of the beverage, according to a study published by the American Psychological Association.

3 Dec 2010

Fake pot now illegal

The U.S. Drug Enforcement Administration (DEA) had to resort to its emergency powers this Wednesday to ban K2 and other “fake pot” products that mimic the effects of marijuana. As of now it is illegal to possess or sell the five chemicals used to make the products for at least one year. The agency and the Department of Health and Human Services will further debate whether the chemicals should be permanently added to the federal list of controlled substances considered unsafe, highly abused and without medical use.

24 Nov 2010

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and social effects on people with the disease, their families and caregivers.

20 Nov 2010

Acacia subsidiary receives patents for wireless physiological monitoring technology

Acacia Research Corporation announced today that a subsidiary has acquired 11 patents for wireless physiological monitoring technology.

19 Nov 2010

FDA approves new drug application for NEXTERONE Premixed Injection

Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.

19 Nov 2010

Anti-stroke blood thinner shows promise in large clinical trials

In new and extensive clinical trials an experimental blood thinner called rivaroxaban is at least as good at preventing strokes as the drug warfarin – that has been the most widely used agent for the past five decades in people with erratic heartbeats called atrial fibrillations. Researchers said this Monday that this drug also sharply reduces the risk of major bleeding that is seen with warfarin.

16 Nov 2010

Bereaved patients have increased heart rate and reduced heart rate variability: Study

The death of a spouse or child can cause elevated heart rate and other potentially harmful heart rhythm changes among the recently bereaved, according to research presented at the American Heart Association's Scientific Sessions 2010.

15 Nov 2010

FDA grants SEDASYS System appeal

Ethicon Endo-Surgery, Inc. (EES) today announced that the Commissioner's Office of the U.S. Food and Drug Administration (FDA) has granted the appeal of the Center for Devices and Radiological Health's (CDRH) denial of the SEDASYS System Premarket Approval Application (PMA). As a result, a new Independent Advisory Panel will be appointed to reconsider the SEDASYS System clinical trial data and application.

11 Nov 2010

Physical activity level decreases among college students

During college years, students become more sedentary and as their physical activity levels decrease, Body Mass Index and weight increase. Basically, students came out of college significantly less active and heavier compared to the start of their freshman year, said Jeanne Johnston, assistant professor in the School of Health, Physical Education and Recreation.

11 Nov 2010

Microwave vital signal sensing measures heart rate variability

Current medical techniques for monitoring the heart rate and other vital signs use electrodes attached to the body, which are impractical for patients who want to move around. Plasma physicist Atsushi Mase, a scientist at Kyushu University in Japan, and colleague Daisuke Nagae have developed a new technique to disconnect people from their electrodes by using microwaves.

11 Nov 2010

Pleasurable activity also reduces stress by inhibiting anxiety responses

Whether it's food or sex, pleasurable activity provides more than just pleasure, University of Cincinnati (UC) researchers say. It actually reduces stress by inhibiting anxiety responses in the brain.

11 Nov 2010

American Specialty Health wins Silver California Fit Business Award for fourth time

Health and wellness company American Specialty Health Incorporated (ASH) announced that it had received a Silver California Fit Business Award for the fourth time from the California Task Force on Youth and Workplace Wellness.

9 Nov 2010

Fearless behavior in children related to neurological and genetic predisposition

"The results of this study show that fearless behavior in children can be identified and is related to neurological and genetic predisposition. This type of behavior has less correlation - at least in infancy - with standards of educational processes or parenting practice," says Dr. Inbal Kivenson-Baron, who carried out the study.

9 Nov 2010

MAP Pharmaceuticals reports positive results from LEVADEX QT trial for migraine

MAP Pharmaceuticals, Inc. today reported successful results from a thorough QT trial of its investigational LEVADEX™ orally inhaled migraine therapy. The trial evaluated the potential of a supra-therapeutic dose to cause an increase in the QT interval. Results of the trial showed that a supra-therapeutic dose of LEVADEX does not increase QTc intervals. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

8 Nov 2010

Top 10 Medical Innovations for 2011

From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases.

3 Nov 2010

Study suggests heredity may play a role in determining infant's susceptibility to AOP

A potentially life-threatening challenge characterized by pauses in breathing that can last for more than 20 seconds, apnea of prematurity (AOP) affects more than 50 percent of premature infants and is almost universal in the smallest of preemies. Caused in part by an underdeveloped central nervous system that can't adequately regulate breathing outside of the womb, especially during sleep, AOP is not yet fully understood by scientists and remains a grave concern among neonatologists and parents alike.

3 Nov 2010

Eating disorders negatively affect oral health

While the connection between oral health and systemic health has been well-established, what most people don't know is that dentists often are in a position to detect systemic conditions. According to an article published in the October 2010 issue of AGD Impact, the monthly newsmagazine of the Academy of General Dentistry (AGD), dentists may be the first health care providers to notice evidence of an eating disorder, such as anorexia nervosa, bulimia nervosa, binge eating disorder, and pica.

29 Oct 2010

Coadministration of INTUNIV tablets with stimulant reduces ADHD symptoms

Shire plc the global specialty biopharmaceutical company, today presented research results of once-daily INTUNIV (guanfacine) Extended-Release Tablets, coadministered with stimulants in children and adolescents diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) who had suboptimal response to treatment with a long-acting stimulant alone.

29 Oct 2010

VIVUS receives FDA CRL for QNEXA NDA

VIVUS, Inc. announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.

29 Oct 2010

Chillies for diabetes: Study

Researchers from Tasmania, Australia are recruiting volunteers in a study to explore if eating chillies can help control lifestyle-related diabetes. At present they need 35 people with type 2 diabetes or glucose intolerance.

28 Oct 2010